Solvay Pharmaceuticals Saves $1.5 Million and Meets Validation Requirements with VMware Virtual Infrastructure

Solvay Pharmaceuticals Saves $1.5 Million and Meets Validation Requirements with VMware Virtual Infrastructure

Cover
Solvay Pharmaceuticals, Inc. is the U.S. subsidiary of the research driven group of pharmaceutical companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology and men's and women's health.

In this case study learn how the implementation of VMware infrastructure increased scalability and performance in the datacenter. As a result, Solvay Pharmaceuticals:

  • Saved more than $1.5 million in hardware costs
  • Decreased paperwork and server procurement costs
  • Achieved server consolidation ratio of 10:1
  • Increased CPU utilization from 0-5 percent to 15-25 percent
  • Facilitated server management with VirtualCenter; four people manage more than 100 servers
  • Decreased server deployment time from 6 hours to 30 minutes
  • Achieved 585 days of continuous uptime
Vendor:
VMware, Inc.
Posted:
18 Jun 2007
Published:
01 Jan 2006
Format:
PDF
Length:
4 Page(s)
Type:
Case Study
Language:
English
Already a Bitpipe member? Login here

Download this Case Study!

By submitting your email address, you agree to receive emails regarding relevant topic offers from TechTarget and its partners. You can withdraw your consent at any time. Contact TechTarget at 275 Grove Street, Newton, MA.

You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

Safe Harbor